title: Methodological Reporting Quality of Randomized Controlled Trials in 3 Leading Diabetes Journals From 2011 to 2013 Following CONSORT Statement: A System Review.
abstract: To appraise the current reporting methodological quality of randomized clinical trials (RCTs) in 3 leading diabetes journals.We systematically searched the literature for RCTs in Diabetes Care, Diabetes and Diabetologia from 2011 to 2013.Characteristics were extracted based on Consolidated Standards of Reporting Trials (CONSORT) statement. Generation of allocation, concealment of allocation, intention-to-treat (ITT) analysis and handling of dropouts were defined as primary outcome and "low risk of bias." Sample size calculation, type of intervention, country, number of patients, funding source were also revealed and descriptively reported. Trials were compared among journals, study years, and other characters.A total of 305 RCTs were enrolled in this study. One hundred eight (35.4%) trials reported adequate generation of allocation, 87 (28.5%) trials reported adequate concealment of allocation, 53 (23.8%) trials used ITT analysis, and 130 (58.3%) trials were adequate in handling of dropouts. Only 15 (4.9%) were "low risk of bias" trials. Studies at a large scale (n > 100) or from European presented with more "low risk of bias" trials than those at a small scale (n ≤ 100) or from other regions. No improvements were found in these 3 years.This study shows that methodological reporting quality of RCTs in the major diabetes journals remains suboptimal. It can be further improved to meet and keep up with the standards of the CONSORT statement.
authors.affiliation: From Graduate Management Unit, Changhai Hospital Affiliated to the Second Military Medical University, Shanghai, PR China (XZ and YW); Department of Orthopedics, Changhai Hospital Affiliated to the Second Military Medical University, Shanghai, PR China (XZ and ML); Department of Endocrinology, Changhai Hospital Affiliated to the Second Military Medical University, Shanghai, PR China (QH and QW); Department of Neurosurgery, the First Hospital of Jilin University, Jilin, PR China (QM); and Department of Neurosurgery, Hongqi Hospital of Mudanjiang Medical University, Heilongjiang, PR China (QM).
authors.forename: Xiao
authors.initials: X
authors.lastname: Zhai
authors.forename: Yiran
authors.initials: Y
authors.lastname: Wang
authors.forename: Qingchun
authors.initials: Q
authors.lastname: Mu
authors.forename: Xiao
authors.initials: X
authors.lastname: Chen
authors.forename: Qin
authors.initials: Q
authors.lastname: Huang
authors.forename: Qijin
authors.initials: Q
authors.lastname: Wang
authors.forename: Ming
authors.initials: M
authors.lastname: Li
mesh_terms: D003920:Diabetes Mellitus / Q000628:therapy*; D005378:Financial Support; D006801:Humans; D010506:Periodicals as Topic / Q000592:standards* / Q000706:statistics & numerical data*; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D012107:Research Design